Dr. Niyongere is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
22 South Greene Street S9D04C
Baltimore, MD 21201Phone+1 410-328-8708Fax+1 410-328-6896
Education & Training
- University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2018
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2012 - 2015
- University of Alabama School of MedicineClass of 2012
- McGaw Medical Center of Northwestern UniversityInternship, Internal Medicine
Certifications & Licensure
- MD State Medical License 2018 - 2025
- FL State Medical License 2015 - 2019
- IL State Medical License 2012 - 2015
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax for relapsed/refractory acute myeloid leukemia.Yuchen Liu, Dominique R Bollino, Osman M Bah, Erin T Strovel, Tien Van Le
Blood. 2024-10-22 - Olanzapine within steroid-sparing antiemetic regimen to prevent chemotherapy-induced nausea and vomiting in patients with acute leukemia receiving multi-day intensive ...Grace Hsu, Ciera Bernhardi, Justin Lawson, Vu H Duong, Ashkan Emadi
Journal of Oncology Pharmacy Practice. 2024-10-01 - Outcomes of Patients with Myeloid Malignancies and Cardiovascular Disease Undergoing Allogeneic Stem Cell Transplantation.Gabriela Sanchez-Petitto, Olga Goloubeva, James Childress, Tahreem Iqbal, Jack Masur
Acta Haematologica. 2024-08-27
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: